Consultant, Infectious Diseases, Department of Medicine
Abdulraman Abdulmohsin Alrajhi
Dr. Alrajhi graduated from King Saud University, Saudi Arabia. He is trained in Internal Medicine and Infectious Diseases at the Brigham and Women’s Hospital in Boston. He has a Masters’ degree in Public Health from Harvard School of Public Health. At King Faisal Specialist Hospital and Research Centre. He was the Head, Section of Infectious Diseases and Chairman, Department of Medicine.
His practice and research focus on chronic infections in the immunocompromised host and tuberculosis. He has 62 group meeting abstracts, and 71 publications in peer reviewed journals including the New England Journal of Medicine and Clinical Infectious Diseases. Areas of interest include infectious diseases epidemiology and tuberculosis in the immune-compromised host.
On the Medical Education front, he established the Section of Continuing Medical Education as the Associate Executive Director, Academic and Training Affairs at King Faisal Specialist Hospital and Research Centre. He became the Deputy Executive Director, Academic and Training Affairs, and rose to be the Executive Director. He is also a Professor of Medicine, Alfaisal University. In recognition of his excellent contribution to the field of medical education, he was awarded the Dr. Mark Hoffman Award for Leadership in Graduate Medical Education by the American Academy of Continuing Medical Education in 2007.
Adibul Hassan Rizvi
Director, Sindh Institute of Urology and Transplantation (SIUT)
Adibul Hassan Rizvi
Professor Adibul Hassan Rizvi was born in Karachi in 1939. He received his education there, ultimately gaining MD in 1961, from the University of Karachi. He then moved to the UK and got a fellowship in surgery and worked in various hospitals there until 1971. Returning to Pakistan, he was appointed Assistant Professor of Urology in Civil Hospital in Karachi.
He is now working as director of the Sindh Institute of Urology and Kidney Transplantation (SIUT), as well as Professor at Dow Medical College in Karachi (since 1992).
SlUT is the pioneer of cadaver organ transplantation in Pakistan. In 1995, Professor Rizvi and his team successfully carried out the first cadaver renal transplant in the country. The kidney used was donated to SIUT by the Euro Transplant Foundation, the largest centre for coordinating transplant activities in Europe. To date, SIUT has performed more than 1,200 renal transplants with a remarkable success rate comparable to the developed world. Had it not been for Professor's Rizvi's humanitarian service, thousands of patients would have suffered and died in silence, with no help whatsoever forthcoming.
Professor Rizvi's contributions to medicine have not gone unrecognized. He has been given several awards in recognition of his service. One of them being the Hunterian Professorship for the year 2002-2003 from the Royal College of Surgeons of England, one of the most coveted awards in the field of surgery in Europe, and especially in England.
Anthony J. Clarkson
Director of Organ Donation and Transplantation
Anthony J. Clarkson
Communication Notify Project (WHO)
United Arab Emirates
Chair, Surgical Subspecialties Institute Cleveland Clinic Abu Dhabi
Bashir Sankari attended medical school at the American University of Beirut. He completed Urology residency 1981-1986 at St Louis University, St Louis, Missouri, and fellowship in Renal Transplantation and Renal Vascular Surgery 1989-1991 at the Cleveland Clinic Foundation, Cleveland, Ohio. Dr. Sankari is a staff urologist at the Glickman Urology and Kidney Institute at the Cleveland Clinic.
General Director, Spanish National Transplant Organization
Beatriz Domínguez-Gil is a medical doctor (PhD) in internal medicine, and specialised in Nephrology. She joined the medical team of the Spanish National Transplant Organization (Organización Nacional de Trasplantes- ONT) in November 2006 and became its Director General in May 2017. ONT is acknowledged worldwide for the development of the so-called Spanish Model on Organ Donation and Transplantation, leading Spain to extraordinary levels of deceased donation. In her position at the ONT, she has been mainly involved in international cooperation through different organisations, promoting and participating in a range of initiatives targeted to enhance organisational models, and quality and safety of organ donation, procurement and allocation, and to the fight against organ trafficking.
On behalf of the European Committee on Organ Transplantation at the Council of Europe, Beatriz Domínguez-Gil co-authored the Joint Study of the Council of Europe and the United Nations on Trafficking in organs, tissues and cells and trafficking in human beings with the purpose of the removal of organs. This study called for the development of an international treaty, which became a convent pen for signature called Council of Europe Convention against Trafficking in Human Organs that includes provisions for its prosecution and prevention, as well as for the protection of its victims. She is chair of the European Committee on Organ Transplantation (CD-P-TO) and president of the Iberoamerican Network/Council on Organ Donation and Transplantation. She has more than 100 publications in scientific journals and book chapters.
Benedict L. Phillips
Transplantation Surgery Guy's and Thomas' NHS Foundation Trust
Benedict L. Phillips
People's Republic of China
Director of Organ Procurement Organization The First People's Hospital of Kunming
Immediate Past Chair, Korean Soc. Transplantation
Curie Ahn is a transplant Nephrologist and immunologist with major interest in xeno transplantation in Seoul, Republic of Korea. Dr. Curie Ahn is the Director of Transplantation Center, Seoul National University Hospital, Director of Department of Graduate School of Immunology, Seoul National University College of Medicine, and Vice President of Transplantation Research Institute in Seoul National University.
Associate Vice Chair for Research
Dorry Segev, MD, PhD, is the Marjory K. and Thomas Pozefsky Professor of Surgery and Epidemiology and Associate Vice Chair of Surgery at Johns Hopkins University. He is the founder and director of the Epidemiology Research Group in Organ Transplantation (ERGOT), the largest and most prolific group of its kind in the world. Dr. Segev was the first to demonstrate the survival benefit of incompatible kidney transplantation across the United States, and is responsible for the first HIV-to-HIV transplants in the United States. His NIH-funded research includes kidney exchange, desensitization, long-term donor risk, access to transplantation, expanding transplantation including HIV+ donors, geographic disparities, post-transplant outcomes, and the intersection between transplantation and gerontology. With a graduate degree in biostatistics, Dr. Segev focuses on novel statistical and mathematical methods for simulation of medical data, analysis of large healthcare datasets, and outcomes research.
Dr. Segev has published over 400 peer-reviewed research articles, including 15 in JAMA, NEJM, and Lancet and over 150 in the American Journal of Transplantation. Reflecting this publication track record, he was recently awarded the American Society of Transplantation's Clinical Science Investigator Award. He is a current councilor of the American Society of Transplant Surgeons and former chair of the American Transplant Congress. His work has directly influenced policy, including two Congressional bills (the Norwood Act for kidney exchange and the HOPE Act for HIV-to-HIV transplants).
Paediatrics & Child Health, Children's Hospital at Westmead
United Arab Emirates
Mohammed Bin Rashid University of Medicine and Health Sciences
Faissal A.M. Shaheen
Director of SCOT
Faissal A.M. Shaheen
MBBch. Facharzt(Austria), FSM(Neph), FRCP(UK), FACP(USA) Head of Nephrology. Dr. Suleman Fakeeh Hospital, Jeddah Senior Consultant of Internal Medicine and Nephrology Director General, Saudi Center for Organ Transplantation 1993-May 2018 Founder of Jeddah Kidney Center in 1993. Executive Editor of SJKDT from 1994. Councilor member of the Transplantation Society (TTS), DICG, MESOT, ISODP. President Elect ISODP (International Society for Organ Donation and Procurement) 2019-2021 Co-Chairman of the Donation and Transplantation Task Force of the WHO (World Health Organization)
Prof. Shaheen’s main interests are organ donation and transplantation policies and procedures, along with updating guidelines. In addition to the chronic kidney diseases, guidelines for renal replacement therapy and prophylaxis. He has 28 memberships in national and international societies, 181 full papers and 190 abstracts in different national and international journals. Prof. Shaheen has also attended a total of 394 national and international conferences.
Fayez Al Shamsi
Fayez Al Shamsi
Francis L. Delmonico
Chief Medical Officer, New England Organ Bank
Francis L. Delmonico
Francis L. Delmonico, M.D. FACS is a Professor of Surgery Harvard Medical School at the Massachusetts General Hospital, where he is Emeritus Director of Renal Transplantation. He has been a member of the MGH Department of Surgery for 35 years. He is the Past-President of The Transplantation Society (2012-2014) and appointed as an Advisor to the World Health Organization in matters of organ donation and transplantation since 2006. Dr. Delmonico is the Medical Director of the New England Organ Bank since 1995. He is the Senior Advisor and former Executive Director of the Declaration of Istanbul Custodian Group. In 2005, Dr. Delmonico was elected President of the United Network for Organ Sharing (UNOS), the federally designated Organ Procurement Transplant Network (OPTN) that oversees the practice of transplantation in the United States. He served on numerous UNOS Committees and was elected by his colleagues in New England as its regional representative to UNOS Board of Trustees in 1988. He was a co-recipient of the Prince of Asturias award on behalf of The Transplantation Society in 2010 for his efforts in the establishment of the Declaration of Istanbul. Dr. Delmonico is the recipient of the Shumakov Medal from the Moscow Institute of Transplantation and the Gold Medal of the Catalan Transplantation Society. He was awarded an Honorary Doctorate from the Pan American University of Mexico City.
ISODP Scientific Program Chair
Günter Kirste, MD, PhD, studied at the Faculty of Medicine, FU Berlin and University of Freiburg. He is Professor of Surgery at the Albert Ludwigs University, Freiburg where he served as the Head of the Section of Transplant Surgery. His scientific career was dedicated to development and improvement of Donation, both living and deceased. He performed the first case of paired kidney transplantation in Europe and the first case of ABO-i LD in Germany.
His positions included General Secretary of the German Transplantation Society (DTG); Member of the Executive Board of the National German Organ Transplantation Foundation (DSO); Founding Member of the European Transplant Coordinators Organization (ETCO) and numerous positions in different National and European bodies of health care.
Over 9 years he was the Medical Director of the DSO. He is a Past- President of the ISODP and currently Chairman of the Scientific Committee.
Gene Y. Sung
Director of Neuro Critical Care
Gene Y. Sung
Dr. Sung is Director of Neurocritical Care and Stroke at the University of Southern California. He is a recognized international leader in both fields of stroke and neurocritical care. He was a founding member of both the international Neurocritical Care Society (and a Past-President), the Western States Stroke Consortium and the LA Stroke Society. He is also a founder of the journal Neurocritical Care and a past associate editor. Furthermore, he has had leadership roles in many national organizations, including the American Academy of Neurology, American Stroke Association and the National Stroke Association and has published and reviewed articles for many journals and has been an invited lecturer in conferences throughout the world.
Dr. Sung’s research interests include stroke outcomes, critical care management of stroke, intracranial pressure, cerebral reperfusion, and hypothermia. He is the principal investigator for several investigator-initiated and industry-sponsored translation research projects and he recently received funding to examine outcomes in telemedicine delivery of stroke care.
ProfessorAlfred Hospital and Monash University
Professor Greg Snell MBBS FRACP MD OAM is currently the Medical Head of the Lung Transplant Service at the Alfred Hospital and Monash University. After completing his initial medical training at University of Melbourne, he completed the Will Rogers Clinical Fellowship in Lung Transplantation at the University of Toronto, Canada in 1992. He has been involved in the implementation of new techniques and technologies in lung transplantation, in particular, the use of Donation-after-circulatory-death (DCD) lungs.
Medical Director Reconstructive Transplant Program Mayo Clinic
Dr. Hatem Amer is an Associate Professor of Medicine at Mayo Clinic College of Medicine and holds joint appointments as a Transplant Nephrologist in the Division of Nephrology and Hypertension, and the William J. von Liebig Center for Transplantation and Clinical Regeneration. Dr. Amer is the Associate Center Director for quality, the founding Medical Director of the Reconstructive Transplant Program and the Renal Transplant Fellowship Director.
Dr. Amer obtained his medical degree at the University of Cairo. There he pursued internal medicine and nephrology graduate training as well as at the Cairo Kidney Center. He moved to the United States where he completed an Internal Medicine Residency at Abington Memorial Hospital in Abington, PA, and Nephrology and Renal Transplant training at Mayo Clinic Rochester, MN.
Dr. Amer serves as councilor for the International Society of Vascularized Composite Allotransplantation (ISVCA) and Member of the Board of Directors of the American Society for Reconstructive Transplantation (ASRT) and is a member of the Education Committee of the Transplantation Society. He is the co-chair of the joint working group charged by the ASRT/ISVCA to define success and failure in face transplantation. He previously served on the American Society of Transplantation’s Renal Transplant Fellowship Accreditation Committee and the Kidney Pancreas Advisory Council. He is a Fellow of the American Society of Nephrology and the American Society of Transplantation. In 2015 Dr. Amer was awarded a Karis Award by the Mayo Clinic Values Council.
National Medical Director, DonateLife
Dr Helen Opdam is the National Medical Director of the Australian Organ and Tissue Authority. She is a Senior Intensive Care Specialist at the Austin Hospital in Melbourne.
Helen has been involved in organ donation since 1998, initially in developing an audit to determine the potential for organ donation. She was the inaugural Victorian State Medical Director for Organ and Tissue Donation at the time that the National Reform to boost donation in Australia began in 2009. She is a Council member of the International Society for Organ Donation and Procurement, and participates on key Australian committees including the Australian and New Zealand Intensive Care Society (ANZICS) Death and Organ Donation Committee and the National Health and Medical Research Council Expert Advisory Group for the development of ethical guidelines for organ transplantation from deceased donors. She is a regular invited speaker at national and international conferences.
Washington University School of Medicine St. Louis Pathology & Immunology & Internal Medicine (Renal)
Present & Recent Positions: Professor of Pathology and Immunology Washington University School of Medicine, St. Louis, MO (1991-2014), retired Professor of Internal Medicine (Nephrology) Section Head Renal Pathology Co-director of Clinical Electron Microscopy Laboratory Co-director WU Kidney Translational Research Core, O’Brian Kidney Center President of the renal pathology Society (RPS) 2014 Staff Pathologist at Arkana Labs (Nephropath) 2014-16 Senior Consultant at ARKANA Labs (Nephropath)
Other past & current positions Other past & current positions Associate Editor British Medical Journal BMC-Nephrology Chair of the Banff Working Group on universal criteria for Implantation Biopsies for Kidney transplants (2011-15) Co-Chair Banff Working Group on Thrombotic Microangiopathy (TMA) in the Transplant Kidney (2015-current) GUREGN Consortium: renal pathologist for the pediatric MID-NORTHWEST USA pediatric group.(2016-current) American Society of Nephrology (ASN) Post Graduate Education Committee (PGE) member on behalf of Renal Pathology (ASN- PGE 2013-18) Chair International Pediatric Nephrology (IPNA) Renal Pathology Course 2016 Budapest Summer Nephrology School (BNS) Renal Pathology Program chair and teaching faculty (2014-17)
Peer review publications >145
Books/book chapters >50
Invited lectures >100
Academic Medical Center, University of Amsterdam
Hessel is currently employed as a postdoc clinical epidemiologist at the Center for Experimental and Molecular Medicine (CEMM), at the Academic Medical Center Amsterdam in the Netherlands. He obtained his bachelor’s degree in health sciences, and received his research master’s degree in the field of epidemiology at the VU University. He obtained his doctoral degree in the field of transplant nephrology, where the focus was on elderly deceased donor kidney transplants and to find factors on how to increase the donor potential in the elderly. He likes to work with transplant professionals, design research related to clinical questions, and apply statistical methods.
President and CEO, Gift of Life Donor Program
Howard Nathan is the President & CEO of Philadelphia-based Gift of Life Donor Program which now employs over 200 professionals. Mr. Nathan began working at the Gift of Life Donor Program in 1978 as a transplant coordinator and has led the organization since 1984.
Gift of Life is the largest and one of the oldest of the 58 organ procurement organizations in the United States, coordinating more than 47,000 organs for transplantation and more than 1,000,000 tissue allografts since 1974.
Mr. Nathan is also Founder and President of Gift of Life Institute, an international research and training center for donation and transplantation professionals established in 2004, and President of Gift of Life Family House.
Considered a leading authority on organ and tissue donation, Mr. Nathan serves or has served on numerous leadership boards including United Network for Organ Sharing (UNOS), Association of Organ Procurement Organizations (AOPO), the International Society for Organ Donation and Procurement (ISODP), Pennsylvania Governor’s Organ Donation Advisory Committee, North American Transplant Coordinators Organization (NATCO), among others.
Mr. Nathan is a regular presenter at national and international organ and tissue procurement and transplantation conferences and has authored or co-authored more than 300 scientific papers and abstracts in his 40-year tenure with Gift of Life. He has appeared on national TV news and talk shows and has received numerous outstanding achievement awards from national organizations.
Chief Executive Officer & President Nevada Donor Network
Joe Ferreira began his role as the Chief Executive Officer and President of Nevada Donor Network in April 2012. Joe brings years of experience and expertise in the Organ Procurement field. He spent 14 years at Life Alliance Organ Recovery Agency in Miami, Florida where he served as the Director of Clinical Operations for seven years. Joe is a graduate of the University of Miami, with a Bachelor of Science in Microbiology and Immunology. He also received his MBA, with a specialization in HealthCare Administration and Policy, from the University of Miami. He serves as a coach for the Art and Science of Leadership Program at the Wharton School and Fox School of Business. Joe is certified in all aspects of the organ donation and recovery process.
Joe has served as a Member-at-Large on the Association of Organ Procurement Organizations (AOPO) Executive Committee, he is a Certified Member of the National Association of Healthcare Quality (NAHQ), and a past Board Member of the Nevada Chapter of the American College of Health Care Executives (ACHE). He has served as the Chairman of the Procurement Council for the Association of Organ Procurement Organizations (AOPO).
Joe is a published author and presenter on organ donation. He consults internationally and has provided guidance to several foreign governments on the establishment or improvement of organ donation and transplant systems based on the US model. He was also the recipient of the Kruger Award for Outstanding Professional Transplant Services by the Transplant Foundation in Miami.
Islamic Republic of Iran
CEO, Iranian Society of Organ Donation
Dr. Katayoun Najafizadeh is a Pulmonary Disease Specialist who established the Lung transplant program in 2000 in Iran. In 2004 she also established organ donation program in one of the main Universities of Tehran to increase the rate of organ donation for patients on transplant waiting lists especially on the list of lung transplant which was her main concern. With her colleagues and their hard works they could perform some projects for increasing the donation rate in this University and could get the family consent rate of 96% and make a PMP of 32.4 in its area with 10 million population.
She was assigned the Director of Organ donation and Transplantation Office of the Ministry of Health of Iran in 2014. Again, her colleagues and she presented some projects to the Minister of Health and with his approval and Iranian Supreme Transplant Council confirmation they started these projects in the country and could increase the organ donation rate in Iran significantly. She also with the best of Iranian Transplant and also Culture and Art experts of Iran established a NGO named ‘Iranian Society of Organ Donation’ to help the Ministry of Health Transplant Management Center especially in issues like social awareness activities, Donor family support, Donor teams education, research and every other related activities which is needed to improve organ donation and transplantation in Iran.
Adult Transplant Nephrologist King Faisal Specialist Hospital & Research Centre
Dr. Khalid Al Meshari, MD, FACP, FAST is a Clinical Professor of Medicine at Alfaisal University, Riyadh, Saudi Arabia, Consultant Adult Transplant Nephrology, Department of Kidney and Pancreas Transplantation at King Faisal Specialist Hospital and Research Center (KFSH&RC), Fellow of the American College of Physicians (FACP), Fellow of the American Society of Transplantation (FAST), and the previous Chairman of the Department of Kidney and Pancreas Transplantation at KFSH&RC, Riyadh, Saudi Arabia.
Additionally, he is the Acting Section Head of Immunopathology, Department of Pathology and Laboratory Medicine at KFSH&RC, and Chairman of the National Paired Kidney Donation Committee at Saudi Center for Organ Transplantation (SCOT) and Director of HLA and ABO Incompatible Kidney Transplantation and Paired Kidney Donation (PKD) at KFSH&RC. Presently he is the Director of International Affairs, General Corporate Consultancy at KFSH&RC.
He is an American Board certified in medicine and nephrology, and ASHI certified Director of HLA and Immunogenetics Laboratory. During his tenure as Director of Renal Transplant Unit and later as the Chairman of the Department of Kidney and Pancreas Transplantation (2001-2013), he led the most active and advanced renal transplant program in the region (the first ever to be accredited by AST for fellowship training outside North America).
Fields of clinical and research interests include HLA and ABO incompatible transplants, ECD kidney transplants, Paired Kidney Donation and long-term outcome of kidney transplantation. He has numerous publications in speer review journals.
Assistant Professor in Critical Care Dalhousie University
Dr. Kristina Krmpotic is a paediatric intensivist at IWK Health Centre and Assistant Professor in the Department of Critical Care at Dalhousie University in Halifax, Canada. Following her clinical training and board certification in paediatrics and paediatric critical care medicine, she completed a clinical research fellowship and obtained an MSc in Evidence-Based Health Care from the University of Oxford. Her primary research interests are in the areas of organ donation and the epidemiology of critical illness in children.
University of Valencia
Marina Berenguer is a Consultant Hepatologist at La Fe University Hospital, Valencia, (Spain). She trained in medicine at the University of Valencia, before completing a fellowship at the VA Medical Center / University of California (USA), with Dr. T. Wright. Professor of Medicine at the University of Valencia, Faculty of Medicine. Professor Berenguer is well recognized for her important contributions to the field of post-transplantation HCV liver disease. She was involved in the creation of various consensus documents on viral hepatitis and liver disease and is an active committee member for several national and international hepatology and liver transplantation societies. She has received numerous grants for her research in antiviral therapy for hepatitis C and awards for her medical research. Since its creation in 2006, she has also co-ordinated research within a national research network in hepato-gastroenterology (“Centro de Investigación Biomédica en Red En Enfermedades Hepáticas y Digestivas”, CIBER-ehd). Associate editor for Journal of Hepatology and Liver Transplantation from 2011 to until 2014. Deputy editor for Transplantation since 2015. She has authored more than 150 publications in peer-reviewed journals as well as over 50 chapters in international and national textbooks.
President TPM-DTI Foundation
Martí Manyalich, MD, PhD, anesthesiologist, is Assessor on Transplantation, Medical Direction, Hospital Clinic, Barcelona; Associate Professor, Medical School, University of Barcelona; and President of the TPM-DTI Foundation, Past President ISODP-TTS and TTS European Councilor.
He created the deceased and living donation program in the Hospital Clinic of Barcelona in 1985 and the TSF multi-tissue bank in 1994. He is an expert in organ and tissue donation, training donor procurement, and tissue banking at national and international level. Among the most important positions he has occupied, he was the former president of the European Transplant Coordinators Organization (ETCO, the former vice president of the European Association of Tissue Banks (EATB) and, from 2015 until September 2017, he was the President of the International Society for Organ Donation and Procurement (ISODP). He is currently European Councilor of The Transplantation Society (TTS) for 2018-2021.
Dr. Matthew Weiss practices pediatric critical care medicine at the CHU de Quebec - Universite Laval (CHUL). He obtained his medical degree from the University of Kansas and then immigrated to Canada to pursue his residency in pediatrics and a subspecialization in pediatric critical care medicine at McGill University. He joined the pediatric critical care team at the CHU de Quebec - Universite Laval in 2010.
Dr. Weiss is an assistant clinical professor in the Faculty of Medicine at Universite Laval, in the department of pediatrics, and member of the CHU de Quebec Universite Laval research centre. His academic activities are mainly focused on organ donation, and he is funded by the Canadian Blood Services to assist in the development of clinical practice guidelines. He is an active member of the Canadian Critical Care Trials Group, and the medical director of organ donation at Transplant Quebec.
United Arab Emirates
Chief Infectious Diseases Department Cleveland Clinic Abu Dhabi
Dr. Mohamad is the Chair of the Infectious Diseases Department and the Antimicrobial Stewardship program, a Staff Physician in the Medical Subspecialties Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Mohamad served as the Head of the Infectious Diseases Division at Eastern Maine Medical Center in Bangor, Maine, US.
Dr. Mooty received his medical degree from the American University of Beirut, Lebanon. He completed his residency in Internal Medicine at the State University of New York Downstate Medical Center in Brooklyn, New York, US, where he also completed his fellowship in Infectious Diseases.
United Arab Emirates
President of EMAN
Mona Alrukhaimi is Professor of Medicine at Dubai Medical College, United Arab Emirates, Consultant physician & Nephrologist and Director of Alrukhaimi Polyclinic and Ex-Head of Medical and Renal Department, Dubai Hospital.
She is the current President of the Emirates Medical Association Nephrology Society, Vice- President of Arab society of Nephrology & Renal Transplantation and the leader of the KDIGO Implementation Task Force for the Middle East & African Regions. She is elected as a member of WHO Task Force on Donation and Transplantation of Human Organs and Tissues (2018-2021). She was the ISN Council (2011-2017), ISN Executive Committee Member (2015-2017) and Ex-chair of ISN Middle East Region. She is the first female Nephrologist and Internist in UAE. Graduated from the University of Kuwait in 1983 and subsequently received her MRCP (UK) in 1989, FRCP Edinburg - 2001 and FRCP London - 2005
She was a member of the Steering Committee for Women in Transplantation under TTS. She is a regular examiner at the Royal College of Physician of UK. She is country investigator in DOPPS 5 and 6.
She Co-Chaired the 13th MESOT Meeting in 2012 and chaired the 12th Congress of the Arab Society of Nephrology and Renal Transplantation (ASNRT) & The 6th ISN-EMAN Update Course in Nephrology in 2014. ,br>Prof. Alrukhaimi has received various prestigious awards, including the Ministry of Education Award, UAE (1976), Sheikh Rashid AlMaktoum Award for Postgraduate achievement (1989), the National Kidney Foundation International Distinguished Medalist, USA (2007) , Sheikh Hamdan Bin Rashid AlMaktoum Award for Medical Science (2012) and a special honor and award of recognition by Gulf Medical University (2012).
The Hospital for Sick Children, University of Toronto
President, Kuwait Transplant Society
Mustafa Al-Mousawi is a graduate of London university, UK. He is president of Kuwait transplant society, consultant surgeon and chairman at Kuwait organ transplant center and Council member of TTS representing Middle East and Africa. ,br>He established organ procurement from deceased donors in Kuwait which is presently among top four countries in the Middle East in this field. He was in the steering committee leading to the Declaration of Istanbul and was co-chair of the patient affairs committee of DICG and member of ethics committee of TTS. He was also president of the Middle East Society for Organ Transplantation (MESOT).
Chief of Department, Hopital Necker Enfants-Malades, University de Paris
Dr. Olivier Aubert is a 33-year-old Nephrologist at the Department of Nephrology and Kidney Transplantation at Necker Hospital in Paris, France. He is currently assistant professor at the Paris Translational Research Center for Organ Transplantation. As a part of his PhD in biostatistics, he spent a one-year fellowship in the Alberta Transplant Applied Genomics Center, Edmonton, Canada with Dr. Philip Halloran. His research interest focuses on transplantation using kidneys from expanded criteria donors, antibody mediated rejection of kidney allografts and the relationship with graft histological lesions, molecular phenotype, and allograft outcome. His team developed a new approach of extremely well phenotyped cohorts that has been extended to heart and lung transplants.
Peter J. Friend
Director of Oxford Transplant Centre
Peter J. Friend
Professor Peter Friend obtained his medical degree from the University of Cambridge (Magdalene College). He is a Fellow of the Royal College of Surgeons (Eng) and has a doctoral degree (MD) from the University of Cambridge. He is the Professor of Transplantation, University of Oxford and an Honorary Consultant Surgeon at Oxford University Hospitals NHS Foundation Trust, specialising in organ transplantation and hepatobiliary surgery. He is also Director of the Oxford Transplant Centre and Fellow of Green Templeton College.
Peter has authored more than 200 scientific papers, is a member of the Council of the Royal College of Surgeons and of the International Transplantation Society. He is a past-president of the British Transplantation Society. Peter is also one of the co-founders of OrganOx, a spin-out company from the University of Oxford, established to develop novel ways to preserve and repair donor transplant organs.
President of MESOT, Ein Shams University
Dr Refaat Kamel MBBCh, F.R.C.S, F.I.C.S., M.D., Hon EBT is the President of Middle East Society of Organ Transplantation (M.E.S.O.T.). Dr Kamel has published more than 700 papers in local and International Journals. Dr Kamel graduated from Ain Shams University and did his residency in Kings College Hospital- London. His current positions are the following
Academic: Professor of Liver transplantation and hepatobiliary surgery, ASU, Egypt Clinical: Director of the national liver transplant program
Chief liver transplant surgeon in three leading liver transplant programs in Egypt since 2001 with an overall experience of more than 750 Living Donor Liver Transplants Chairman of Refaat Kamel hospital for hepatobiliary and liver transplantation Surgery Honorary fellow of the European Board of Transplantation North African representative of MESOT since 2012 Secretary general of the Egyptian section of the International College of Surgeons Editor in the Experimental and clinical Transplantation Journal Editor in International Surgery Egypt representative in the Mediterranean Transplant Network Board member for establishing the organ donation law in 2010 Head of the communication committee in the supreme Egyptian council of organ transplantation TTS councillor 2008 Member of the Istanbul Declaration on organ trafficking and Transplant tourism and active member of the custodian group
Richard D. Hasz
Vice President of clinical services, Gift of Life Donor Program
Richard D. Hasz
Richard Hasz is the Vice President of Clinical Services for the Gift of Life Donor Program. Rick oversees the day-to-day clinical operations of the program, including Transplant Coordination, Hospital Development, Organ Preservation, Quality Assurance, and Tissue Recovery. A past President of the Board of Governors for the American Board of Transplant Certification. Rick holds membership in the North American Transplant Coordinator’s Organization; The American Society of Transplant Surgeons, and the American Association of Tissue Banks.
President of United Therapeutics Corporation
Professor of Pediatrics, McGill University
Division of Paediatric Critical Care, Montreal Children's Hospital McGill University Health Centre and Research Institute Professor of Paediatrics, McGill University Honourary Staff Physician, Department of Critical Care Medicine, Hospital for Sick Children, University of Toronto Medical Advisor (Deceased Donation), Organs and Tissues, Canadian Blood Services
Dr. Shemie’s area of interest is organ replacement during critical illness. He is a paediatric critical care physician, ECMO specialist and trauma team leader at the Montreal Children’s Hospital, McGill University Health Centre. He is a Professor of Paediatrics at the Montreal Children’s Hospital, McGill University and honourary staff in the Department of Critical Care Medicine, Hospital for Sick Children, University of Toronto. He is medical advisor, deceased organ donation, with Canadian Blood Services. His academic focus is advancing the science and practice of deceased organ donation. His research interests include the clinical and policy impact of organ failure support technologies, the development and implementation of national ICU-based leading practices in organ donation and research at the intersection of end-of-life care, death determination and deceased donation.
Sarah E. van Pilsum
Research Assistant, Johns Hopkins Medicine
Sarah E. van Pilsum
Sarah Rasmussen is a research assistant. She studied Medical Anthropology at Macalester College and researched gender bias in transplantation in Nepal as a Fulbright Scholar. She uses qualitative methods to study the ethics of current issues in transplantation, including living donation, HIV-to-HIV transplants and HCV-positive to HCV-negative transplants.
Chairman and founding CEO of Sylvatica Biotech and Ossium Health
Dr. Giwa is Chairman and was founding CEO of the two biotechs, Sylvatica Biotech and Ossium Health. There he raised significant funding from leading VCs, industry as well as from the National Institutes of Health and the US Army. He also helped oversee the development of a clinical grade, fully industrialized, cGMP processing capability and receiving FDA "go ahead" for multiple uses/indications of a lead product. Dr. Giwa was the founding CEO of the Organ Preservation Alliance where he for instance launched new global initiatives at the White House and still serves on the Executive Committee of the American Society of Transplantation's Organ Preservation and Procurement branch. Other experience includes trading analytics and investment research at world leading hedge fund, Bridgewater Associates, consulting at Bain, equity research at Goldman Sachs and serving two terms as the President of the National Youth Council of Sweden. Dr. Giwa holds a PhD in Economics (conducted at SSE, Harvard and MIT) and an MBA from Harvard where he graduated with High Distinction and was named a Baker Scholar.
Transplant Registrar, Royal Papworth Hopsital
Senior Consultant, University Hospital Essen
Dr. Tamas Benkö is an assistant professor and leader of the program of HPB Surgery and Transplant Surgery at the Department of General and Transplant Surgery at the University Hospital Essen, Germany.
He graduated and acquired his PhD from the Semmelweis University in Budapest, Hungary in optimizing the living donor liver transplantation and effects of various donor pretreatments after partial hepatectomy.
His clinical focus is on both oncological surgery (upper GI, lower GI, HPB, etc.) including laparoscopic techniques and transplant surgery (liver, kidney, pancreas). He is a fellow of the European board of Surgery, Division of Transplantation and HPB Surgery and is member of various international societies. Dr. Benkö’s areas of research interests include surgical education, surgical oncology, liver surgery, transplant surgery, ischemia reperfusion injury, hepatocellular carcinoma (HCC), cholangiocellular carcinoma (CCC), liver regeneration and living related transplantation, organ transplantation from donors with extended criteria. He has published over 20 peer-review articles in the most prestigious scientific journals. He is also board certified in general surgery, visceral surgery adding special visceral surgery, and transplantation surgery.
Thomas A. Nakagawa
Chief, Division of Pediatric Critical Care Medicine
Thomas A. Nakagawa
Thomas A. Nakagawa, M.D., FAAP, FCCM, is a pediatric critical care specialist. Most recently, he was a Professor of Anesthesia and Critical Care Medicine at Johns Hopkins University School of Medicine where he served as Chief of Critical Care, Director of the Pediatric Intensive Care Unit, and Medical Director for Respiatory Care at Johns Hopkins All Children’s Hospital in St. Petersburg, Florida. Prior to joining Johns Hopkins University School of Medicine, Dr. Nakagawa was the Section Head of Pediatric Critical Care, Director of the Pediatric Intensive Care, and Medical Director of Respiratory Care at Brenner Children’s Hospital, Wake Forest Baptist Hospital, in Winston-Salem, NC. Dr. Nakagawa continues to serve as the Assistant Medical Director for Carolina Donor Services in Durham, North Carolina.
Dr. Nakagawa is actively involved with issues pertaining to end-of-life care, organ and tissue donation, neurologic and circulatory determination of death, and ethical issues. Dr. Nakagawa currently serves on the Secretary of Health of Health and Human Services, Advisory Committee on Organ Transplantation (ACOT). He is a past member of the UNOS/OPTN Pediatric Transplant committee. Dr. Nakagawa was national faculty and co-chair for the Organ Donation and Transplantation Breakthrough Collaboratives sponsored by U.S. Department of Health and Human Services, Health Resources and Service Administration (HRSA). He has co-chaired three National Pediatric Organ Donation Summits in the US. Dr. Nakagawa served as co-chair of the Organ Donation and Transplantation Alliance donor management taskforce committee and he currently serves on the Board of Directors for the Organ Donation and Transplantation Alliance as the Society of Critical Care Medicine liaison.
Vivek B. Kute
Dept. of Nephrology and Transplantation Dr. H.L. Trivedi Institute of Transplantation Sciences
Vivek B. Kute
Hospital das Clínicas/Universidade Federal de Minas Gerais
Wanessa Clemente currently works as a professor at the School of Medicine of the Federal University of Minas Gerais (UFMG), Brazil and she has been working in the field of Transplant Infectious Diseases (TID) for nearly 20 years as a consultant for Liver and Digestive transplant service. Her area of interest lies in quality and safety in transplantation, travel and tropical medicine, and healthcare-associated infections.
Quite recently she had a very interesting opportunity to be the chief editor for a guideline published last year (2018) regarding “Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America”.
She at present is working on projects related to transplant infectious diseases associated with medical tourism and quality metrics in transplantation.